Total Count 17

JAMJOOM PHARMA - Argaam Reports

30/04/2025
Jamjoom Pharma revises guidance for next 3 years 
Argaam Special
21/04/2025
Highest-paid executives, board members of Saudi-listed firms in 2024
Argaam Special
30/01/2025
Jamjoom Pharma Q4 2024: What are analysts predicting?
Argaam Special
23/12/2024
Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024
Argaam Special
27/10/2024
Jamjoom Pharma maintains 2024 guidance
Argaam Special
24/10/2024
What do analysts expect from Jamjoom Pharma's Q3 2024 results?
Argaam Special
06/10/2024
Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024
Argaam Special
11/09/2024
How analysts rated Jamjoom Pharma after Q2 results?
Argaam Special
05/08/2024
Analyst forecasts on Jamjoom Pharma Q2 2024 profit
Argaam Special
04/07/2024
Key events likely to impact Saudi-listed firms’ earnings in Q2 2024
Argaam Special
21/04/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special
16/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special
20/02/2024
Jamjoom Pharma seen to post profit growth in Q4 2023
Argaam Special
09/01/2024
How did analysts view TASI performance, top picks for 2024?
Argaam Special
05/12/2023
How did analysts view Jamjoom Pharma’s Q3 financials?
Argaam Special
30/09/2023
TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainers
ِArgaam special
10/08/2023
Jamjoom Pharma revises up 2023 guidance
Argaam Special

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request